WallStSmart
CPRX

Catalyst Pharmaceuticals Inc

NASDAQ: CPRX · HEALTHCARE · BIOTECHNOLOGY

$28.26
-4.01% today

Updated 2026-04-29

Market cap
$3.45B
P/E ratio
16.82
P/S ratio
5.86x
EPS (TTM)
$1.68
Dividend yield
52W range
$19 – $33
Volume
1.5M

Catalyst Pharmaceuticals Inc (CPRX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-1.18M$-4.42M$-8.26M$-7.68M$-3.76M$-4.99M$-5.14M$-9.88M$-12.94M$-18.02M$-17.96M$-13.74M$-25.70M$34.61M$45.03M$60.37M$116.05M$143.60M$239.81M$208.67M
Capital expenditures$21053.00$65872.00$1345.00$2298.00$2867.00$3620.00$52382.00$9432.00$57323.00$23465.00$96061.00$92018.00$92018.00$19373.00$11394.00$1.02M$29000.00$81.74M$556000.00$58000.00
Depreciation
Stock-based comp$1.22M$556343.00$717568.00$601438.00$450089.00$416735.00$340039.00$175855.00$777969.00$1.59M$1.84M$2.41M$3.55M$3.82M$6.26M$6.07M$7.91M$14.25M$22.25M$24.78M
Free cash flow$-1.20M$-4.49M$-8.26M$-7.69M$-3.76M$-4.99M$-5.19M$-9.89M$-13.00M$-18.04M$-18.06M$-13.83M$-25.80M$34.59M$45.02M$59.35M$116.02M$61.86M$239.25M$208.61M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$553909.00$-4.62M$806019.00$6.88M$19.14M$-14.34M$43.60M$-40.94M$72.95M$41.21M$126.95M